Receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin (RANKL/RANK/OPG) axis has been hypothesized as a potential mediator of left ventricular hypertrophy (LVH). The aim of the study was to assess whether circulating concentrations of RANKL, RANK, and OPG were associated with early signs of morphological cardiac changes in overweight/obese youths.
Association of OPG-RANKL ratio with left ventricular hypertrophy and geometric remodeling in male overweight/obese youths / Zampetti, S; Lucantoni, F; Pacifico, L; Campagna, G; Versacci, P; Pierimarchi, P; Buzzetti, R. - In: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. - ISSN 1720-8386. - STAMPA. - (2018). [10.1007/s40618-018-0932-y]
Association of OPG-RANKL ratio with left ventricular hypertrophy and geometric remodeling in male overweight/obese youths
Zampetti, S;Lucantoni, F;Pacifico, L;Campagna, G;Versacci, P;Buzzetti, R
Ultimo
2018
Abstract
Receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin (RANKL/RANK/OPG) axis has been hypothesized as a potential mediator of left ventricular hypertrophy (LVH). The aim of the study was to assess whether circulating concentrations of RANKL, RANK, and OPG were associated with early signs of morphological cardiac changes in overweight/obese youths.| File | Dimensione | Formato | |
|---|---|---|---|
|
Zampetti_Association-OPG-RANKL_2018.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
3.82 MB
Formato
Adobe PDF
|
3.82 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
